Adjuvant Therapy for Stage II Colon Cancer: A Systematic Review From the Cancer Care Ontario Program in Evidence-Based Care’s Gastrointestinal Cancer Disease Site Group
Top Cited Papers
- 15 August 2004
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 22 (16), 3395-3407
- https://doi.org/10.1200/jco.2004.03.087
Abstract
Purpose To develop a systematic review that would address the following question: Should patients with stage II colon cancer receive adjuvant therapy? Methods A systematic review was undertaken to ...Keywords
This publication has 44 references indexed in Scilit:
- A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly PatientsNew England Journal of Medicine, 2001
- Should Dukes' B patients receive adjuvant therapy? A statistical perspectiveSeminars in Oncology, 2001
- Adjuvant intraportal chemotherapy for Dukes B2 and C colorectal cancer also receiving systemic treatment: results of a multicenter randomized trialAnti-Cancer Drugs, 2000
- Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trialThe Lancet, 1999
- 1297: Adjuvant therapy: how effective, and for which patients? A meta- analysisEuropean Journal Of Cancer, 1997
- Final results of a phase III clinical trial on adjuvant intraportal infusion with heparin and 5-fluorouracil (5-FU) in resectable colon cancer (EORTC GITCCG 1983–1987)European Journal Of Cancer, 1997
- ElderlyAnnals of Oncology, 1996
- Combined intraperitoneal plus intravenous chemotherapy after curative resection for colonic adenocarcinomaEuropean Journal Of Cancer, 1995
- Five year results of a randomized trial of adjuvant 5-fluorouracil and levamisole in colorectal cancerBritish Journal of Surgery, 1987
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986